作者
T Li, Y Zhang, L Fu, C Yu, X Li, Y Li, X Zhang, Z Rong, Y Wang, H Ning, R Liang, W Chen, LA Babiuk, Z Chang
发表日期
2005/5
期刊
Gene therapy
卷号
12
期号
9
页码范围
751-761
出版商
Nature Publishing Group
简介
SARS-CoV (the SARS-Associated Coronavirus) was reported as a novel virus member in the coronavirus family, which was the cause of severe acute respiratory syndrome. Coronavirus replication occurs through a unique mechanism employing Leader sequence in the transcripts when initiating transcription from the genome. Therefore, we cloned the Leader sequence from SARS-CoV (BJ01), which is identical to that identified from SARS-CoV (HKU-39849), and constructed specific siRNA targeting the Leader sequence. Using EGFP and RFP reporter genes fused with the cloned SARS-CoV Leader sequence, we demonstrated that the siRNA targeting the Leader sequence decreased the mRNA abundance and protein expression levels of the reporter genes in 293T cells. By stably expressing the siRNA in Vero E6 cells, we provided data that the siRNA could effectively and specifically decrease the mRNA …
引用总数
20052006200720082009201020112012201320142015201620172018201920202021202220232024271145153231122222476
学术搜索中的文章